ALEXANDRIA, Va., March 29 -- Ameritox, Baltimore, has been assigned a patent (9,606,132) developed by four co-inventors for "methods of monitoring adherence to lurasidone therapy." The co-inventors are Jeffrey Enders, High Point, North Carolina, Erin Strickland, Greensboro, North Carolina, Gregory L. McIntire, Greensboro, North Carolina, and Ayodele Morris, Midland, Texas.

The patent application was filed on Dec. 11, 2014 (14/567,935). The full-text of the patent can be found at h . . .